Denali Therapeutics Parkinson's Patent, C07D 403/14
Summary
Denali Therapeutics Inc. obtained EPO publication of patent application EP4329763A1, titled 'METHODS FOR TREATING AND MONITORING PARKINSON'S DISEASE', classified under C07D 403/14 and published on 15 April 2026. The application designates all EU member states as covered contracting states. Three inventors are named: Danna L. Jennings, Vinay M. Daryani, and Sarah Huntwork-Rodriguez. Patent publications create no immediate compliance obligations but establish intellectual property rights that may affect freedom-to-operate assessments for competitors in Parkinson's therapeutics.
About this source
GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 63 changes logged to date.
What changed
The EPO published patent application EP4329763A1 for Denali Therapeutics Inc., covering methods for treating and monitoring Parkinson's disease. The application, classified under C07D 403/14 (organic chemistry, heterocyclic compounds), was published on April 15, 2026 with an A1 publication kind indicating inclusion of the search report. The designation covers all EU contracting states listed, including Germany, France, the United Kingdom, Italy, Spain, and other member states.
Affected parties include pharmaceutical companies developing Parkinson's disease therapeutics, contract research organisations, and licensing professionals who should assess freedom-to-operate implications for any overlapping pipeline compounds. The patent publication does not create immediate compliance obligations but initiates the opposition window and establishes priority dates that may affect future patent strategies in this therapeutic area.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS FOR TREATING AND MONITORING PARKINSON'S DISEASE
Publication EP4329763A1 Kind: A1 Apr 15, 2026
Applicants
Denali Therapeutics Inc.
Inventors
JENNINGS, Danna L., DARYANI, Vinay M., HUNTWORK-RODRIGUEZ, Sarah
IPC Classifications
A61K 31/506 20060101AFI20250127BHEP C07D 403/14 20060101ALI20250127BHEP A61P 25/16 20060101ALI20250127BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.